Abstract:To discover novel fluoroquinolone lead compounds as possible anti-infective or/and antitumor chemotherapies, combination principle of pharmacophore-based drug design, a series of novel tricyclic fluoroquinolone title compounds, [1,2,4]triazino[3,4-h][1,8]naphthyridine-8-one-7-carboxylic acid derivatives ( 5a-5p), were designed and synthesized with a fused [1,2,4]-triazine ring unit. Their structures were characterized by spectral data and elemental analysis and the in vitro antibacterial and anti-cell proliferation activities were also evaluated. The results showed that the titled compounds exhibited more significant inhibitory activities against drug-resistant bacteria (Methicillin-resistant Staphylococcus aureus and multi drug-resistant Escherichia coli strains) and three tested cancer cell lines (human hepatoma SMMC-7721, murine leukemia L1210 and human murine leukemia HL60 cells). Interestingly, SAR showed that compounds with electron-donating groups attached to benzene ring had stronger antibacterial activity than antitumor activity, but electron-withdrawing compounds displayed more potential antitumor activity than antibacterial activity, especially antitumor activity of nitro compounds was comparable to comparison doxorubicin. Thus, novel triazine-fused tricyclic fluoroquinolones as potent anti-infective or/and antitumor lead compounds are valuable to pay attention and for further development.

Synthesis And Antibacterial Activity Of New Tetracyclic Triazolothiadiazino Fluoroquinolones

Synthesis and Antibacterial Activity of 8-Substituted Phenyl-1-Pyridin-3-Yl-5h-Bis[1,2,4]Triazolo[3,4-B;4 ',3 '-D][1,3,4] Thiadiazines

Synthesis and antibacterial activity of 7-substited-5-azaspiro[2, 4] hept-5-yl quinolone-3-carboxylic acids

Synthesis, structure and antibacterial activity of new 2-(1-(2-(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-tetrahydroisoquinoline derivatives.

[Synthesis and Antibacterial Activity of 7-(7-aminomethyl-5-azaspiro [2,4] Hept-5-yl)-1-cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid and Its Analogues].

SYNTHESES OF NOVEL FLUOROQUINOLONE COMPOUNDS

4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: novel C7 moieties of fluoroquinolones as antibacterial agents.

[Synthesis and Antibacterial Activity of 5-Amino-6, 8-Difluoro-1-(5-fluoro-2-pyridyl)-7-(3-methyl-1-piperazinyl)-1, 4-Dihydro-4-oxo-3-quinolinecarboxylic Acid and Its Analogues].

The synthesis and biological evaluation of a novel series of C7 non-basic substituted fluoroquinolones as antibacterial agents.

The Synthesis and Activity in Vitro of A Series of 5-Amino-8-methoxyquinolones

The Synthesis and Activity in Vitro of a Series of 8-Difluoromethoxy Quinolones: Analogues of Gemifloxacin

[Synthesis and Antibacterial Activity of 3-(4-piperazin-1-yl-phenyl)-s-triazolo [3,4-B] [1,3,4] Thiadiazole Hydrochlorides].

Synthesis and in vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines.

Synthesis and Antibacterial Activities of Novel 4-Substituted-6-(4-chlorophenyl)-7-(lh-1,2,4-triazol-1-yl)-1 ',2 ',4 '-Triazolo[3,4-b]1 '',3 '',4 ''-Thiadiazines

Synthesis and Antibacterial Activities of Novel Biphenyltetrazole Derivatives Bearing 1,3,4-Oxadiazole

Synthesis and biological activities of novel quinazolinone derivatives containing a 1,2,4-triazolylthioether moiety

[Design, synthesis, antibacterial and anti-cell proliferation activities of [1,2,4]triazino[3,4-h] [1,8]naphthyridine-8-one-7-carboxylic acid derivatives]

[Synthesis and Antibacterial Activity of 2-(3-pyridyl)-5-([(5-aryl-1,3,4-oxadiazol-2-yl) Methylene]thio)-1,3,4-oxadiazoles].

Synthesis and in Vitro Antibacterial Activities of 7-(3-aminopyrrolo[3,4-c]pyrazol-5(2h,4h,6h)-yl)quinolone Derivatives

[Synthesis and Antibacterial Activity of 3-(5-substituted Phenyl-[1,3,4] Oxadiazole-2-yl-methylenethio)-5-pyridin-3-yl-[1,2,4] Triazole-4-yl-amines].

Synthesis and in Vitro Antibacterial Activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone Derivatives.